A. K. Rud

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer

G. Mælandsmo, O. Brustugun, S. Solberg, 2012, BMC Cancer.

Clinical significance of disseminated tumour cells in non-small cell lung cancer

G. Mælandsmo, E. Borgen, Å. Helland, 2013, British Journal of Cancer.

Osteopontin is a prognostic biomarker in non-small cell lung cancer

G. Mælandsmo, Å. Helland, O. Brustugun, 2013, BMC Cancer.

EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery

L. Kleinberg, Thomas Fleischer, Å. Helland, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer

G. Mælandsmo, O. Brustugun, S. Solberg, 2012, BMC Cancer.

Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer

G. Mælandsmo, Å. Helland, O. Brustugun, 2016, Diagnostic Pathology.

Osteopontin is a prognostic biomarker in non-small cell lung cancer

G. Mælandsmo, Å. Helland, O. Brustugun, 2013, BMC Cancer.

EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery

L. Kleinberg, Thomas Fleischer, Å. Helland, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.